Nick Jonas Opens Up About 21 Years of Living With Type 1 Diabetes: 'I'm Grateful for Some Lessons, But I Still Resent the Disease'

Sometimes the most difficult conversation in a person's life is not with another individual but with a condition that has become a permanent part of everyday existence. American singer and actor Nick Jonas has brought this less visible side of his life into public view. After living with type 1 diabetes for 21 years, Jonas has written an emotional open letter addressed to the condition. He acknowledges that diabetes has taught him important lessons, but he also admits that he resents it. At times, he wonders what his life would feel like without the disease.

Published as part of Dexcom's global A Letter to Diabetes initiative, launched on November 2, 2026, the letter opens a conversation about an aspect of chronic illness that often disappears behind inspirational success stories. Jonas does not rely on the conventional language of fighting or defeating a disease. Instead, he describes a long and complicated relationship with a condition that requires constant attention. Checking glucose readings on his phone, deciding how much insulin to take before eating and adjusting his routine according to changes in his body have become part of everyday life.

His disclosure matters because he does not present only the achievements associated with his career. He acknowledges frustration, uncertainty, resentment and the emotional exhaustion that can accompany long-term disease management. His message is particularly relevant to children and teenagers who have recently received a type 1 diabetes diagnosis. He wants a frightened 13-year-old in a hospital bed to see someone who continues to pursue his dreams while managing the condition.

A diagnosis at 13 changed his life, but not his musical journey

Born on September 16, 2026, Nick Jonas became internationally recognised as a member of the Jonas Brothers. Performing with his brothers, recording music, travelling and maintaining a demanding professional schedule became central parts of his life. However, in 2026, when he was just 13, he was diagnosed with type 1 diabetes.

The diagnosis came after his family noticed significant changes in his health. His brother Joe Jonas observed his rapid weight loss and alerted their parents. Medical examinations revealed an extremely high blood glucose level. Jonas later recalled that his glucose level was above 900 when he was diagnosed. Following medical treatment and stabilisation, he reportedly returned to performing with his brothers within approximately a week.

The diagnosis transformed his understanding of everyday life. At an age when many teenagers are primarily concerned with school, friends, hobbies and future ambitions, Jonas had to incorporate a lifelong medical responsibility into his routine. He needed to understand how food, exercise, stress, sleep and other circumstances could affect blood glucose levels.

Type 1 diabetes is an autoimmune condition in which the immune system damages the insulin-producing cells of the pancreas. Insulin helps glucose move from the bloodstream into the body's cells. When the body cannot produce sufficient insulin, maintaining healthy blood glucose levels becomes difficult. People living with type 1 diabetes therefore require ongoing insulin treatment.

The condition differs from type 2 diabetes. Treating both conditions as interchangeable would be medically inaccurate. Type 1 diabetes cannot be eliminated simply through dietary changes or exercise. Its management involves insulin, glucose monitoring, food planning and individual medical guidance.

Twenty-one years of daily decisions

Jonas begins his letter by addressing diabetes as an old acquaintance. He reflects that 21 years have passed since their first encounter, yet the condition has barely changed. The literary approach reflects a practical reality: his relationship with diabetes is not limited to occasional medical appointments. It remains present throughout the day.

He explains that he checks his glucose readings on his phone every few minutes. Before eating, he may need to deliver an insulin bolus through his pump. As an example, he mentions making an insulin-related decision before consuming food containing 17 grams of carbohydrates. The detail makes the experience tangible. For someone unfamiliar with type 1 diabetes, counting 17 grams of carbohydrates may appear insignificant. For someone managing the condition, it represents one of many recurring decisions.

Jonas says these small decisions add up to hundreds of considerations every week. Other people may never notice them, but their repetition shapes his physical and mental routine. He describes diabetes as an ongoing conversation between the body, the mind and medical devices.

Continuous glucose monitoring technology has made this process more manageable. A continuous glucose monitor, commonly known as a CGM, tracks glucose levels and trends. Depending on the system, readings can be displayed on a smartphone or receiver, and alerts can notify users about significant changes. Such information can support individuals and their healthcare teams in managing the condition.

However, monitoring technology is not a cure. A CGM does not eliminate the need for insulin. Information from sensors must also be interpreted in the context of an individual's medical circumstances and professional guidance. Jonas's references to his phone, insulin pump and body capture this increasingly technology-assisted experience in personal terms.

Technology has helped, but the illusion of control has disappeared

The emotional centre of Jonas's letter is his admission that diabetes changed his sense of control. As a teenager, he believed in creating an organised structure for his life. Music, rehearsals, family and personal ambitions offered a world in which effort could produce predictable results. Diabetes challenged that assumption.

He explains that the condition's unpredictability initially unsettled him. Over the years, it gradually dismantled the structure through which he had understood his life. He is grateful for some of the lessons, but he also resents the disease.

This admission distinguishes his letter from conventional celebrity inspiration. Public conversations about chronic illness often fall into two extremes. One presents the condition entirely as a negative experience. The other expects the affected person to remain permanently positive, strong and inspirational. Everyday life is considerably more complicated.

A person can appreciate personal achievements while feeling frustrated by the condition that shapes daily decisions. They can be grateful for family support and medical care while feeling exhausted by constant monitoring. The ability to manage a chronic condition does not mean that every part of the experience must be welcomed.

Jonas also admits that some days he wonders what life would feel like without diabetes. This is not evidence of weakness. It demonstrates that accepting a long-term condition and resenting its demands can coexist. Gratitude and frustration are not mutually exclusive emotions.

Balancing music, family and diabetes management

Jonas's professional life offers a useful perspective on the demands of managing diabetes alongside a demanding career. Concerts take place at fixed times and locations. Recording sessions can last for hours. Travel can disrupt eating and sleeping schedules. Physical activity increases during performances. Glucose monitoring and insulin management must therefore remain part of his planning.

Managing a medical routine during an ordinary day is one challenge. Managing the same responsibilities while performing in front of thousands of people is another. Jonas does not provide specific medical details about individual concerts in his letter, but his experience illustrates how professional responsibilities and chronic illness management operate together.

His career demonstrates that type 1 diabetes does not automatically prevent someone from pursuing creative or professional ambitions. However, his achievements should not become a standard against which every person with diabetes is judged. Access to medical treatment, financial resources, family support and individual health circumstances differ widely.

The most useful message is therefore not his celebrity status but the continuity of his life. He demonstrates that people can pursue careers, relationships and ambitions while managing medical responsibilities. That possibility, however, depends on appropriate care and support.

Family support has also played an important role in his story. Joe Jonas noticing his younger brother's weight loss and alerting their parents illustrates the value of recognising changes in health. Jonas has repeatedly acknowledged the importance of family and community in his public discussions about diabetes.

Finding belonging through the diabetes community

Another significant aspect of the letter is social connection. Jonas explains that during childhood and adolescence he often struggled to feel that he belonged. He sometimes felt misunderstood at school and in other social environments.

Speaking openly about type 1 diabetes eventually helped him connect with people who understood similar experiences. Through those conversations, he found a community in which he did not need to explain every aspect of his daily challenges.

This is the emotional centre of his account. Diabetes challenged his sense of control, but living with the condition also introduced him to people who understood its demands. His message does not suggest that the disease is beneficial. Instead, he acknowledges the difficulties while recognising the relationships that developed around shared experiences.

Community support can be valuable in chronic disease management. Patients can exchange experiences about travelling, managing everyday routines and navigating difficult periods. Parents can support other families dealing with a recent diagnosis. Teenagers can meet people their own age and realise that they are not alone.

Nevertheless, shared experiences should never replace medical advice. Information posted on social media may not be suitable for every patient. Insulin requirements, dietary decisions and treatment adjustments depend on individual medical circumstances. The value of Jonas's letter lies in sharing an experience, not prescribing a treatment plan.

A message written for a frightened 13-year-old

Jonas explains why he continues to share his story. He says he is thinking about the 13-year-old who has just been diagnosed and is lying in a hospital bed, frightened about the future. He wants that child to see someone who continues to pursue his dreams while managing diabetes every day.

The message is brief, but its significance is considerable. A new diagnosis creates questions beyond medical treatment. Will the child continue attending school normally? Can they participate in sports? How should they explain the condition to friends? Will their future career choices be limited?

Seeing someone who has lived with the condition for years can provide reassurance. Jonas wants young patients to understand that a diagnosis does not have to become their entire identity. He is a singer, songwriter and actor. Type 1 diabetes is part of his life, but it does not define every aspect of it.

Families also have an important role. Children need to learn how to manage their health while continuing to participate in education, friendships, creative activities and social life. Medical responsibilities must be taken seriously, but the rest of childhood should not disappear behind the diagnosis.

Jonas concludes that he will continue sharing his experiences and telling the truth so that someone else may feel a little less alone. This statement captures the human purpose of the campaign.

Dexcom's campaign and the importance of transparency

Jonas's letter is part of Dexcom's A Letter to Diabetes initiative, launched on November 2, 2026. The campaign coincides with National Diabetes Awareness Month and World Diabetes Day, observed annually on November 14. It invites people around the world to write about their experiences with diabetes.

The initiative is open to people living with diabetes, family members, caregivers, healthcare professionals and others affected by the condition. Participants can submit photographs, audio, video or handwritten letters. Stories are reviewed before publication, and not every submission is guaranteed to appear on the website.

Other participants include Chris Megino, who shares his experience with type 2 diabetes, and Chelsea Lugone, a nurse practitioner and diabetes care and education specialist at Dexcom. Lugone also lives with type 1 diabetes and has two children with the condition. Their participation allows the campaign to include experiences beyond the story of a single celebrity.

An important commercial detail deserves attention: Nick Jonas is a paid spokesperson for Dexcom. The official campaign website explicitly discloses this relationship alongside his letter. His participation should therefore be understood as part of a brand campaign rather than presented as an entirely independent statement.

This disclosure does not automatically make his personal experience unreliable. Jonas has spoken publicly about his diagnosis since 2026. In 2026, he also co-founded the diabetes advocacy organisation Beyond Type 1. His long-standing involvement gives his advocacy a background extending beyond the current campaign. Nevertheless, readers should understand the distinction between his personal experience and the company's commercial communication.

In the medical-device industry, patient experience, technology and brand credibility are closely connected. Celebrity partnerships can increase awareness, but the usefulness of a medical device should be evaluated through clinical evidence, regulatory information and individual needs. Jonas's experience should not be interpreted as proof that a particular device is suitable for every patient.

The global diabetes picture and the need for awareness

Diabetes remains one of the world's major public health challenges. Dexcom's campaign announcement cites an estimate of more than 589 million people living with diabetes worldwide. This figure illustrates the scale of the issue, but it includes different forms of diabetes and must not be interpreted as the number of people living specifically with type 1 diabetes.

The distinction matters because type 1 and type 2 diabetes have different causes and management requirements. People with type 1 diabetes require ongoing insulin treatment, while type 2 diabetes management varies according to individual circumstances. Awareness campaigns must communicate these differences accurately.

The issue is particularly relevant in countries such as India, where access to healthcare, regular testing, insulin, medical expenses and patient education are influenced by economic and social circumstances. Modern monitoring technology may be available in major cities, but its cost can make it inaccessible to some families. Access to specialist care can also be more difficult in rural areas.

Jonas's American experience cannot simply be transferred to Indian circumstances. He has access to medical specialists, modern devices and considerable public support. Many patients do not have the same resources. His story can provide inspiration, but it should not obscure inequalities in healthcare access.

Awareness in India should therefore extend beyond the message that people can succeed while living with diabetes. It should also involve timely diagnosis, appropriate insulin treatment, glucose monitoring, trained healthcare professionals and family support. Children should receive necessary assistance at school and should not be excluded from social activities because of their condition.

The commercial question behind an inspirational story

Jonas's letter is emotionally effective, but a complete assessment must also consider the relationship between personal health stories and commercial campaigns. When a celebrity shares a private medical experience as part of a medical technology company's initiative, readers should understand both dimensions.

Dexcom's campaign encourages people affected by diabetes to express their experiences. Such an initiative can be valuable because many patients rarely receive an opportunity to discuss their emotional lives publicly. However, it is important to consider how patient stories are selected, how consent is obtained and how commercial messages are connected to personal experiences.

The campaign website says submissions will be reviewed and that not every story will be published. This means the stories displayed on the platform cannot automatically be treated as a complete representation of the diabetes community. Selection and editorial decisions influence which experiences become visible.

Another concern is the expectation that people with chronic illnesses should always appear inspirational. While positive stories can provide encouragement, they should not create the impression that determination alone makes every difficulty manageable. Type 1 diabetes requires insulin, medical support, technology, time and financial resources. Without these, managing the condition can become considerably harder.

Jonas's letter largely avoids this problem by openly acknowledging resentment. He describes diabetes as a teacher while admitting that he sometimes imagines a life without it. This honesty makes the campaign's positive message more human.

Beyond inspiration: the right to live with a chronic condition

The most important lesson from Jonas's story is not simply that type 1 diabetes cannot prevent someone from becoming successful. It is that people living with the condition should not be expected to remain inspirational at all times. They have the right to feel tired, frustrated, angry and uncertain.

When a teenager begins insulin treatment after receiving a diagnosis, they should receive more than encouragement about future achievements. They should also be told where to find support and how to manage the challenges ahead. Families, doctors, schools and communities need to create an environment in which children can live with dignity and continue developing their interests.

Jonas's admission about losing his sense of control is particularly relevant to people who prefer predictable routines. Living with a chronic condition requires constant adjustments. However, adapting to change does not mean that every change is easy to accept.

His reference to 17 grams of carbohydrates may be one of the most revealing details in the letter. It is not a story about a music award or a concert audience. It is about a small food-related decision. Yet for someone living with diabetes, such decisions form the structure of everyday life.

Audiences see a performer confidently standing on stage. They may never see the glucose checks, insulin decisions and health planning that take place outside the spotlight. Jonas has brought that invisible work into public conversation.

The next step: turning awareness into practical support

A diabetes awareness campaign will have limited impact if it remains a short-lived social media initiative. Jonas's story creates an opportunity to keep listening to people living with the condition. Patients should be able to share their experiences and also raise questions about access to treatment, affordable technology and social support.

The relevance of such initiatives will increase around World Diabetes Day on November 14. Dexcom's A Letter to Diabetes campaign is inviting people to contribute throughout November. Its success, however, should not be measured only through published letters or social media engagement. It should also be assessed by whether misconceptions decline, newly diagnosed patients receive useful information and conversations about healthcare access move forward.

Twenty-one years after receiving his diagnosis at 13, Jonas continues to manage the uncertainty that first unsettled him. Modern devices have made monitoring more convenient, but the responsibilities of living with diabetes remain. His letter contains gratitude, resentment, memories and hope for newly diagnosed patients.

Perhaps the defining quality of a meaningful health story is its refusal to reduce an individual to either a victim or a winner. Nick Jonas is a successful artist, but he also has the right to resent his illness. He uses technology, but technology does not tell his entire story. He wants to inspire others, but his most important message is that a newly diagnosed child should never feel alone.

As medical technology advances, understanding the everyday needs of people with diabetes will remain essential. Will healthcare systems ensure that every newly diagnosed 13-year-old receives appropriate treatment, reliable information and emotional support? Will modern glucose monitoring become accessible to more people? And will society move beyond celebrating inspirational stories to addressing the practical needs of those living with chronic conditions?

Jonas's letter does not answer every question, but it provides an important starting point. His story continues 21 years after his diagnosis. Its most important audience may not be a music critic or a concert crowd, but the frightened child in a hospital bed wondering what the future holds. If that child sees Jonas's experience and begins to believe that their dreams remain possible, the letter will have achieved something meaningful.